Presence but not number of secondary type mutations influences outcome in de novo AML without MDS‐associated or recurring cytogenetic abnormalities

A group of gene mutations has been identified to be strongly associated with secondary acute myeloid leukemias (AML) arising from prior myeloid neoplasms. The International Consensus Classification (ICC) and proposed 5th edition of the World Health Organization (WHO) classification differ by inclusi...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinberg, Olga K., Cantu, Miguel D., Gagan, Jeffrey, Madanat, Yazan F., Arber, Daniel A., Hasserjian, Robert P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Short Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435713/
https://www.ncbi.nlm.nih.gov/pubmed/37601841
http://dx.doi.org/10.1002/jha2.710

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10435713/
https://www.ncbi.nlm.nih.gov/pubmed/37601841
http://dx.doi.org/10.1002/jha2.710

Ejemplares similares